Results 201 to 210 of about 721,295 (295)
Seen but Overlooked: Ground-Glass Opacities in Pulmonary Arterial Hypertension. [PDF]
Rayner SG.
europepmc +1 more source
Survival of patients with pulmonary arterial hypertension during therapy PAH-specific drugs
openalex +1 more source
Pharmacological management of arterial hypertension at typical Russian area [PDF]
В. И. Петров
openalex +1 more source
Objective The objective of this study was to test if blood–brain barrier (BBB) disruption, detected using dynamic susceptibility contrast (DSC) imaging, would predict progression of white matter hyperintensities (WMHs) over the subsequent year in patients with chronic cerebrovascular disease. Methods The study included patients with a history of stroke
Richard Leigh +4 more
wiley +1 more source
Potential role of the spleen in the development of arterial hypertension in humans. [PDF]
Nardin M +19 more
europepmc +1 more source
Objective The first‐pass effect (FPE), defined as excellent reperfusion after a single attempt, is associated with improved outcomes in large vessel occlusion stroke. We evaluated whether intravenous tenecteplase (TNK) compared with alteplase (TPA) increases the likelihood of FPE in basilar artery occlusion (BAO).
Dylan N. Wolman +38 more
wiley +1 more source
How It Really Happened-the Development of Inhaled Iloprost for Pulmonary Arterial Hypertension. [PDF]
Olschewski H.
europepmc +1 more source
Objective To evaluate the real‐world safety and efficacy for standard surgical risk patients with extracranial internal carotid artery disease undergoing transcarotid artery revascularization. Methods ROADSTER 3 is a prospective, multicenter, single‐arm post‐approval study.
Jeffrey Jim +15 more
wiley +1 more source

